Navigation Links
Odyssey Thera is First to Install Next Generation High-Content Imaging Capability
Date:11/29/2011

SAN RAMON, Calif., Nov. 29, 2011 /PRNewswire/ -- Odyssey Thera, Inc., a technology provider focused on deciphering biologically-relevant pathways in human cells, announced today that it has installed the IN Cell Analyzer 6000, a laser-based confocal imaging platform from GE Healthcare, to advance the world's largest high-content assay capability.

Odyssey Thera applies a systems biology approach to advance knowledge of the complex cellular networks responsible for biologically–relevant pathway activity. The company has advanced proprietary, cell-based technologies including protein-fragment complementation assays (PCAs) that allow protein-protein complexes to be precisely imaged and localized within live cells.

Using PCA and other technologies, Odyssey has created the world's largest high-content assay capability. Fully-integrated hardware, software and IT infrastructure enables very high throughput, creating a unique systems- and chemical-biology platform capable of capturing and analyzing hundreds of thousands of microscopic images per day.

The IN Cell Analyzer 6000 employs a unique optical engine combined with a next generation sCMOS detector to support high-throughput and high-resolution imaging of diverse biological events. In contrast to conventional fixed aperture confocal systems, the proprietary IN Cell Analyzer 6000 optical system features a fully adjustable variable aperture for increased flexibility.

"The IN Cell 6000 is designed for the most demanding high-content cellular applications, including live cell assays, 3D imaging, co-localization studies and imaging of assays with low signal. The choice of GE Healthcare's IN Cell 6000 reflects Odyssey's goal of maintaining our leadership position in highly contextual cellular analysis," said John K. Westwick, Ph.D., President and CEO of Odyssey Thera.

"The Odyssey team will use the IN Cell 6000 for multiple projects, including advancement of partner drug discov
'/>"/>

SOURCE Odyssey Thera, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Stereotaxis Board of Directors Reaffirms Commercialization Plans for Epoch™ and Odyssey™ Product Platforms
2. Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™
3. Odyssey Thera Announces U.S. Patent for Technologies Enabling Protein Interaction Screening and Directed Evolution
4. Odyssey Thera to Participate in Expanded EPA Initiative
5. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
6. Stereotaxis and Siemens Promote Integrated Odyssey(TM) Solutions
7. Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones
8. Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
9. Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
10. Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1
11. Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 Legislation passed today by ... provision to help prevent inappropriate prescriptions in Medicare Part ... the Integrity of Medicare Act (PIMA) of 2014 , ... Kevin Brady (R-TX) and Ranking Member Jim McDermott ... abuse epidemic and implement the right policies, said the ...
(Date:2/26/2015)... February 26, 2015 LifeScienceIndustryResearch.com ... First -In- Class Innovations and Cost Optimization Plays ... Cap Pharmaceutical Companies research report to the pharmaceuticals ... to this Global Pharma US & EU Outlook ... measurements, divestment of non-core assets result in healthy ...
(Date:2/26/2015)...  BD Life Sciences, a segment of BD ... ), a leading global medical technology company, and ... high-resolution biology, today announced that they will be ... cell isolation and single-cell gene expression analysis. ... FACS™ single-cell sorting instrumentation and software with Cellular ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... SAN FRANCISCO, June 6 OxyBand Technologies Inc., ... the company,s bio-medical,technology development and expand the company,s ... for,health, cosmetic and consumer care. The company,s inaugural ... the FDA for medical and over the,counter marketing. ...
... Data Indicate Overall and Disease-Free Survival -, ... adjuvant trial in,high-risk melanoma patients demonstrated that a ... and/or overall,survival. These findings, which indicate Leukine,s potential ... annual meeting of the American Society,of Clinical Oncology ...
Cached Medicine Technology:OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer 2Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 2Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 3Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 4Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 5
(Date:2/27/2015)... MA (PRWEB) February 27, 2015 ... mobility management services, and one of the ... announced support for Bell Mobility within their CLEAN ... of services. Wireless Analytics’ newly developed Bell ... reporting for the Canadian wireless carrier’s business customers. ...
(Date:2/27/2015)... 2015 A new study published in ... men who cycle on a regular basis and prostate cancer. ... suggests that the more hours per week a man spends ... leading to an increased importance on prostate cancer screening methods. ... look more closely at patents’ risk factors for developing prostate ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 ... “cutters”, are often misunderstood, misdiagnosed and therefore ... to healthy lives. Jacksonville-based addiction treatment ... of its highly acclaimed Lakeview Professional Lecture ... interested in understanding this complicated condition. ...
(Date:2/27/2015)... On March 2-4, the Mesothelioma ... Cancer Institute (NCI) will co-host the annual International ... of Health (NIH), in Bethesda, Maryland. The event ... medical professionals and scientists who specialize in mesothelioma, ... public, including patients, their families, and caregivers. , ...
(Date:2/27/2015)... Altec Products, Inc., announced today that ... as their doc-link for Dynamics Partner of the Year. ... solutions for their customers in all different industries with ... and BPW have worked side-by-side to successfully help clients ... , “We are so impressed by the success that ...
Breaking Medicine News(10 mins):Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 3Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:Lakeview Health to Host Important Workshop Tackling the Rising Issue of ‘Cutters’ on March 27 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 2Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 3
... ATS 2008, TORONTOXScientists believe they may have identified a ... risk of allergy and asthma in childhood. They will ... International Conference in Toronto on Tuesday, May 20., Several ... without allergy at the time of birth. For example, ...
... 21 The Quantum Group,Inc. (Amex: QGP, QGP.WSA, QGP.WSB) ... successfully completed a corporate expansion plan. The Company,increased its ... facility size from 6,600 sq. ft. to 10,600 sq. ... to a larger facility in Doral (west,Miami), Florida., ...
... 21 Crdentia Corp. (OTC Bulletin,Board: CRDT), a leading ... ended March 31, 2008., Revenue in the quarter ... revenue of $9,806,540 and an increase of 31% over ... profit improved to,$2,310,854 in the first quarter of 2008, ...
... ACM today announced a new strategic,alignment that ... next generation technology and services to the two ... commercial plans and,payers, and federal and state governments., ... has been,named EVP/General Manager for Government, and will ...
... sleep apnea (OSA) in very young children may cause ... older children and adults with the condition, according to ... the American Thoracic Societys 2008 International Conference in Toronto ... year of life, said Aviv Goldbart, M.D., the pediatric ...
... that patients with chronic obstructive pulmonary disease (COPD) who ... visits from exacerbations or complications benefit from simple low-intensity ... for COPD was previously shown to reduce hospitalizations for ... a more limited intervention model is effective, said Kathryn ...
Cached Medicine News:Health News:Possible biological explanation for C-Section-linked allergies and asthma found 2Health News:The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009 2Health News:The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009 3Health News:Crdentia Announces 2008 First Quarter Results 2Health News:Crdentia Announces 2008 First Quarter Results 3Health News:Crdentia Announces 2008 First Quarter Results 4Health News:Crdentia Announces 2008 First Quarter Results 5Health News:Crdentia Announces 2008 First Quarter Results 6Health News:Crdentia Announces 2008 First Quarter Results 7Health News:ACM Taps Two Senior Leaders to Head Up New Strategic Initiatives 2Health News:Low-intensity case management cuts COPD-related hospital visits in half 2
... are designed with the clinician in mind. ... be removed to simplify cleaning - no ... unique snap-on mechanism eliminates screws that can ... interchangeable with other green coded fiber optic ...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
... a unique fiberoptic laryngoscope blade that can ... sometimes needed during difficult intubations. The articulating ... blade to be raised by squeezing a ... operation produces a more complete exposure of ...
Medicine Products: